Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms

Leukemia Research

Volumn 32, Issue 10, 2008, Pages 1638-1640

  Fernández Mercado, Marta ^a   Cebrián, Virginia ^a   Euba, Begoña ^a   García Granero, Marta ^a   Calasanz, María J ^a   Novo, Francisco J ^a   Vizmanos, José L ^a   García Delgado, Marina ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; DNA; JANUS KINASE 2; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

BLOOD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CPG ISLAND; DISEASE SEVERITY; GENE INACTIVATION; HUMAN; LETTER; METHYLATION; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

CPG ISLANDS; DNA METHYLATION; FUSION PROTEINS, BCR-ABL; HEMATOLOGIC NEOPLASMS; HUMANS; JANUS KINASE 2; MYELOID CELLS; POINT MUTATION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 44749094529     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.03.014     Document Type: Letter

References (10)

1. Ihle JN. Janus kinases in cytokine signaling. Cell 1996;84:331-4.
2. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., et al. A family of cytokine-inducible inhibitors of signalling. Nature 387 (1997) 917-921
3. Chen C.Y., Tsay W., Tang J.L., Shen H.L., Lin S.W., Huang S.Y., et al. SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia. Genes Chromosomes Cancer 37 (2003) 300-305
4. Liu T.C., Lin S.F., Chang J.G., Yang M.Y., Hung S.Y., and Chang C.S. Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia. Br J Haematol 123 (2003) 654-661
5. Jost E., do O.N., Dahl E., Maintz C.E., Jousten P., Habets L., et al. Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders. Leukemia 21 (2007) 505-510
6. He B., You L., Uematsu K., Zang K., Xu Z., Lee A.Y., et al. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci 100 (2003) 14133-14138
7. Niwa Y., Kanda H., Shikauchi Y., Saiura A., Matsubara K., Kitagawa T., et al. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene 24 (2005) 6406-6417
8. Capello D., Deambrogi C., Rossi D., Lischetti T., Piranda D., Cerri M., et al. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders. Br J Haematol 141 (2008) 504-511
9. Hatirnaz O., Ure U., Ar C., Akyerli C., Soysal T., Ferhanoglu B., et al. The SOCS-1 gene methylation in chronic myeloid leukemia patients. Am J Hematol 82 (2007) 729-730
10. Johan M.F., Bowen D.T., Frew M.E., Goodeve A.C., and Reilly J.T. Aberrant methylation of the negative regulators RASSFIA SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol 129 (2005) 60-65